P

PTC Therapeutics
D

PTCT

45.110
USD
-1.09
(-2.36%)
Market Open
Volume
10,366
EPS
-5
Div Yield
-
P/E
-8
Market Cap
3,479,115,201
OverviewSignalsIdeasNews
Related Instruments
    A
    ABUS
    0.02500
    (0.78%)
    3.22500 USD
    A
    ARCT
    0.760
    (4.90%)
    16.260 USD
    A
    ARWR
    0.080
    (0.41%)
    19.530 USD
    C
    CRNX
    0.460
    (0.86%)
    53.980 USD
    C
    CRSP
    -0.510
    (-1.25%)
    40.210 USD
    G
    GLPG
    0.270
    (1.01%)
    27.000 USD
    R
    RARE
    -0.950
    (-2.15%)
    43.240 USD
    S
    SLDB
    -0.02000
    (-0.48%)
    4.13000 USD
    S
    SRPT
    0.350
    (0.29%)
    119.320 USD
    V
    VKTX
    -0.420
    (-0.99%)
    41.850 USD
    V
    VYGR
    -0.07500
    (-1.30%)
    5.68500 USD
    More
News

Title: PTC Therapeutics

Sector: Healthcare
Industry: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.